Literature DB >> 19556246

Reduced expression of an RNA-binding protein by prolactin leads to translational silencing of programmed cell death protein 4 and apoptosis in newt spermatogonia.

Ko Eto1, Kazufumi Eda, Motoshi Hayano, Syota Goto, Kenta Nagao, Toshihiro Kawasaki, Hiroshi Kashimura, Hiroshi Tarui, Osamu Nishimura, Kiyokazu Agata, Shin-Ichi Abe.   

Abstract

Recent studies indicate that the balance between cell survival and proapoptotic signals determines which cells commit to life or death. We have shown that the balance between follicle-stimulating hormone and prolactin determines differentiation or apoptosis in 7th generation spermatogonia during newt spermatogenesis; however, the molecular mechanisms specifying their fate are poorly understood. Here we show that the newt RNA-binding protein (nRBP) plays a critical role in determining their fate. nRBP was identified as a clone whose mRNA is decreased by prolactin, resulting in the reduction of the protein, which is otherwise expressed predominantly in the spermatogonia. nRBP protein associated with the mRNA for newt programmed cell death protein 4 (nPdcd4) at the 3'-untranslated region. nRBP reduction increased nPdcd4 mRNA but decreased its protein. In a cell-free system, cytoplasmic extracts containing reduced amounts of nRBP and nPdcd4 protein induced apoptosis, whereas adding nRBP protein to the extracts blocked apoptosis. Furthermore, overexpression of nRBP protected cells from apoptosis, stabilized the chimeric transcript containing the nPdcd4 3'-untranslated region, and accelerated its translation. These data suggest that, in the absence of nRBP, nPdcd4 mRNA is not stabilized and its translation is suppressed, leading to apoptosis in the spermatogonia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556246      PMCID: PMC2749100          DOI: 10.1074/jbc.M109.018622

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins.

Authors:  M Görlach; C G Burd; G Dreyfuss
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

3.  A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A.

Authors:  Hsin-Sheng Yang; Myung-Haing Cho; Halina Zakowicz; Glenn Hegamyer; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2.

Authors:  Debnath Mukhopadhyay; Courtney W Houchen; Susan Kennedy; Brian K Dieckgraefe; Shrikant Anant
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

5.  DUG is a novel homologue of translation initiation factor 4G that binds eIF4A.

Authors:  Alexandra Göke; Rüdiger Göke; Anja Knolle; Heidi Trusheim; Harald Schmidt; Andreas Wilmen; Ruaidhri Carmody; Burkhard Göke; Youhai H Chen
Journal:  Biochem Biophys Res Commun       Date:  2002-09-13       Impact factor: 3.575

Review 6.  Hormonal control of meiosis initiation in the testis from Japanese newt, Cynops pyrrhogaster.

Authors:  Shin-ichi Abé
Journal:  Zoolog Sci       Date:  2004-07       Impact factor: 0.931

7.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.

Authors:  Y A Lazebnik; S H Kaufmann; S Desnoyers; G G Poirier; W C Earnshaw
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

8.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.

Authors:  Yuan Chen; Thomas Knösel; Glen Kristiansen; Agnieszka Pietas; Mitchell E Garber; Sachiko Matsuhashi; Iwata Ozaki; Iver Petersen
Journal:  J Pathol       Date:  2003-08       Impact factor: 7.996

9.  Modulation of polyglutamine-induced cell death by genes identified by expression profiling.

Authors:  Hiroko Kita; Jenny Carmichael; Jina Swartz; Shizuko Muro; Andreas Wyttenbach; Kenichi Matsubara; David C Rubinsztein; Kikuya Kato
Journal:  Hum Mol Genet       Date:  2002-09-15       Impact factor: 6.150

10.  Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

Authors:  Aaron P Jansen; Corinne E Camalier; Cristi Stark; Nancy H Colburn
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

View more
  4 in total

1.  Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA.

Authors:  K Eto; S Goto; W Nakashima; Y Ura; S-I Abe
Journal:  Cell Death Differ       Date:  2011-09-30       Impact factor: 15.828

2.  Effects of culture media on the susceptibility of cells to apoptotic cell death.

Authors:  Chikara Anai; Masatoshi Kawaguchi; Ko Eto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-05-02       Impact factor: 2.416

3.  The kinase DYRKIA regulates pre-mRNA splicing in spermatogonia and proliferation of spermatogonia and Sertoli cells by phosphorylating a spliceosomal component, SAP155, in postnatal murine testes.

Authors:  Ko Eto; Yoshiyuki Sonoda; Shin-Ichi Abe
Journal:  Mol Cell Biochem       Date:  2011-05-08       Impact factor: 3.396

4.  A Tissue-Mapped Axolotl De Novo Transcriptome Enables Identification of Limb Regeneration Factors.

Authors:  Donald M Bryant; Kimberly Johnson; Tia DiTommaso; Timothy Tickle; Matthew Brian Couger; Duygu Payzin-Dogru; Tae J Lee; Nicholas D Leigh; Tzu-Hsing Kuo; Francis G Davis; Joel Bateman; Sevara Bryant; Anna R Guzikowski; Stephanie L Tsai; Steven Coyne; William W Ye; Robert M Freeman; Leonid Peshkin; Clifford J Tabin; Aviv Regev; Brian J Haas; Jessica L Whited
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.